Cannabis Stocks
39.53k followers • 23 symbols -1.49% Watchlist by Yahoo Finance
Follow this list to discover and track the stock of publicly traded companies with exposure to cannabis
23 symbols
Get the Yahoo Finance app
- Free real-time data
- News and price alerts
- Add and edit holdings
- Track performance
- Create multiple watchlists
- Barrons.com•2 hours ago
Barclays Is Making Bigger Bets in Marijuana Stocks
(BARC) disclosed last month that it initiated a position in (TLRY) (ticker: TLRY), the Canadian marijuana company, in the third quarter. It owned 26,319 shares of Tilray stock as of Sept. 30, according to a filing Barclays made with the Securities and Exchange Commission. Barclays also greatly increased its investment in another Canadian marijuana producer, (CRON) (CRON).
- Motley Fool•2 hours ago
Who's Next After Canopy Growth's and Cronos Group's Huge Deals?
More big cannabis industry deals could be on the way. But which marijuana producers are the top candidates to partner with major companies outside of the industry?
Zacks•3 hours agoCronos-Altria Deal Boost Marijuana ETF: Will This Continue?
Altria investment in Canadian cannabis producer Cronos sparked a rally in the broad cannabis sector and the its ETF. Will the trend continue?
Market Realist•3 hours agoHumira’s Biosimilar Competition in International Markets
AbbVie (ABBV) expects Humira to report revenue of close to $6.3 billion in international markets in 2018. AbbVie reported Humira sales worth $1.58 billion in international markets in the third quarter, YoY (year-over-year) rises of 1.8% on a reported basis and 4.2% on an operational basis.
- Zacks•4 hours ago
Amgen (AMGN) Continues to Reward Shareholders, Ups Dividend
Amgen (AMGN) hikes its quarterly dividend by 10%.
- Motley Fool•4 hours ago
Say What? A Marijuana Stock Buying Back Its Shares
This newly public pot stock just announced a $50 million share buyback.
Zacks•5 hours agoAre Options Traders Betting on a Big Move in Canopy Growth (CGC) Stock?
Investors need to pay close attention to Canopy Growth (CGC) stock based on the movements in the options market lately.
- Market Realist•4 hours ago
Considering AbbVie’s 2018 Expense Projections
In the third quarter, AbbVie (ABBV) reported SG&A (selling, general, and administrative) expenses of $1.57 billion, a YoY (year-over-year) rise of 8.77%. However, its adjusted SG&A as a percentage of its total revenue was 19.1% in the third quarter, a YoY improvement of 170 basis points. According to AbbVie’s third-quarter earnings conference call, the company benefited from improved operational efficiencies and sales leverage in the quarter.
- Motley Fool•5 hours ago
7 Events That Shaped Canopy Growth's 2018
This helps to explain why Canopy is the largest marijuana stock by market cap.
- Market Realist•5 hours ago
What Citron Research Has to Say about Aphria
Last week was a brutal week for Aphria (APHA) (APHQF). Aphria’s troubles began last Monday when Gabriel Grego of Quintessential Capital Management called the stock “worthless” and explained in detail why he believes the company destroyed shareholder value. Aphria fought back and appointed a special committee that consists of independent directors who will be tasked with reviewing the allegations.
- Market Realist•5 hours ago
Two Cannabis Stocks Made Big Moves Last Week
In the week ending December 8, two big moves gripped the cannabis market. Cronos Group’s (CRON) 45% stake was acquired by Altria, which caused Cronos to gain 39% last week. Aphria (APHA) (APHQF) cut its stock almost in half last week. The cannabis sector, represented by the Horizons Marijuana Life Sciences ETF (HMMJ), fell almost 4%. The ETFMG Alternative Harvest ETF (MJ) declined 1.5% during the same period. Let’s look at how other stocks performed last week.
Market Realist•6 hours agoExploring AbbVie’s Margin Projections for 2018
On its third-quarter earnings conference call, AbbVie (ABBV) said that it expected its gross margin ratio for 2018 to be more than 80.5% and its adjusted operating margin to be close to 45%. In the third quarter, AbbVie reported an adjusted gross margin of 81.7%, a YoY (year-over-year) rise of 90 basis points. It expects a further positive impact of 170–180 basis points on its gross margin in 2019 due to the royalty termination.
- Motley Fool•21 hours ago
Here's Why AbbVie Stock Surged 21.1% in November
Hints of success for the company's blood cancer pipeline encouraged investors last month.
- Motley Fool•yesterday
The Craziest Marijuana Statistic of 2018
Despite no shortage of cannabis milestones, it was an odd year for pot stocks.
- Motley Fool•yesterday
2 Must-Read Quotes on Marijuana From FDA Head Scott Gottlieb
Is cannabis policy reform at the federal level "inevitable?"
- Motley Fool•yesterday
3 Top Stocks to Buy in December
These stocks have one common denominator: Great long-term growth prospects.
- Motley Fool•yesterday
Why Aurora Cannabis, Canopy Growth, and Tilray Have Had a Better Year Than You Might Think
There's more to the story for these Canadian marijuana stocks' gains -- or lack thereof -- in 2018.
- Motley Fool•yesterday
Better Marijuana Stock: Cronos Group vs. GW Pharmaceuticals
Which stock wins in a matchup between this top Canadian marijuana grower and the biggest cannabis-focused biotech?
- Motley Fool•yesterday
Did Gilead Sciences Make an $11 Billion Blunder?
Spoiler alert: The answer is "no."
- Motley Fool•2 days ago
Here's Why Scotts Miracle-Gro Rose 13.8% in November
The home garden specialist announced fiscal 2018 earnings and issued upbeat guidance for fiscal 2019.
- Motley Fool•2 days ago
Better Marijuana Stock: Aurora Cannabis vs. KushCo Holdings
Which stock wins in a matchup between a big marijuana producer and a top ancillary products supplier to the cannabis industry?
- Motley Fool•2 days ago
4 Multibillion-Dollar Industries Canopy Growth Thinks It Will Disrupt
Are Canopy's plans to jump into multiple huge markets only pipe dreams? Not at all.
Associated Press•3 days agoA look at where companies stand on marijuana business
When Canada legalized recreational marijuana in October, it emerged as the world leader in the industry — and U.S. companies are scrambling to get in on the action. Uruguay may have been the first country to legalize pot, but the South American country's market is dwarfed by Canada's. And while a majority of U.S. states have legalized marijuana to varying degrees, contradictory federal laws have U.S. companies reluctant to invest here. — Marlboro maker Altria Group Inc., which is headquartered in Richmond, Virginia, is paying $1.8 billion for a 45 percent stake in Cronos Group.
- Motley Fool•3 days ago
Better Buy: Scotts Miracle-Gro vs. Lowe's
There are two factors to consider when looking at Lowe's and Miracle-Gro: recent performance and marijuana.
